Eversept Partners, LP

CIK

1697013

City

NEW YORK

State / Country

NY

Stock

PCVX — Vaxcyte, Inc.

Top Portfolio Positions

110 positions · $1,817,420,308 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
UTHR	UNITED THERAPEUTICS Corp Healthcare	264,271	$156,707,417	8.62%
QQQ	Invesco Qqq Trust, Series 1	238,700	$137,772,866	7.58%
ABVX	Abivax S.A. Healthcare	934,423	$104,048,001	5.73%
GSK	GSK plc Healthcare	1,785,175	$98,523,808	5.42%
VERA	Vera Therapeutics, Inc. Healthcare	2,173,286	$87,431,295	4.81%
NTRA	Natera, Inc. Healthcare	384,713	$76,938,752	4.23%
SPY	Spdr S&P 500 ETF Trust	107,000	$69,586,380	3.83%
SNDX	Syndax Pharmaceuticals Inc Healthcare	2,885,622	$67,408,129	3.71%
CLDX	Celldex Therapeutics, Inc. Healthcare	1,788,016	$56,715,867	3.12%
PCVX	Vaxcyte, Inc. Healthcare	924,193	$53,704,855	2.96%

Portfolio Trend

25 quarters · across all stocks

Holdings in PCVX

Compact Export CSV

Shares Held

Position Value (USD)

13 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$53,704,855	924,193	-22.8%	Shares	Sole	2026-05-15
2025-12-31	$55,262,893	1,197,722	-15.8%	Shares	Sole	2026-02-17
2025-09-30	$51,219,827	1,421,983	+9.5%	Shares	Sole	2025-11-14
2025-06-30	$42,214,690	1,298,514	+133.1%	Shares	Sole	2025-08-14
2025-03-31	$21,034,963	557,070	+336.6%	Shares	Sole	2025-05-15
2024-12-31	$10,444,353	127,588	+32.8%	Shares	Sole	2025-02-14
2024-06-30	$7,255,680	96,089	-51.3%	Shares	Sole	2024-08-14
2024-03-31	$13,479,680	197,331	-15.6%	Shares	Sole	2024-05-15
2023-12-31	$14,685,089	233,839	+22.8%	Shares	Sole	2024-02-14
2023-09-30	$9,708,121	190,430	-2.7%	Shares	Sole	2023-11-14
2023-06-30	$9,772,808	195,691	-34.6%	Shares	Sole	2023-11-08
2023-03-31	$11,208,394	299,050	+67.6%	Shares	Sole	2023-11-08
2022-12-31	$8,556,821	178,453	—	Shares	Sole	2023-02-14
No 13F history on record for this holder in this stock.